In Creative Compounds, LLC v. Starmark Laboratories, the Federal Circuit clarified that the “clear and convincing” burden of proof applies to an allegation of prior invention unless an action is brought under 35 USC § 291 or the parties identify and agree on common claimed subject matter and seek an adjudication of priority. While Patent Reform may do away with the specific provisions at issue in this case, at least some of the principles may carry over to the proposed “derivation” proceedings.
Tag Archives: Creatine
Subscribe to This Blog
Topics
- 101
- 102
- 103
- Bilski
- Biosimilars
- Claim Construction
- District Court Decisions
- Doctrine of Equivalents
- Duty of Disclosure
- Enablement
- Federal Circuit Decisions
- Inequitable Conduct
- Infringement
- International Patent Practice
- Life Sciences Agreements
- Myriad
- Obviousness Type Double Patenting
- Patent Office Practice
- Patent Reform
- Patent Term Adjustment
- Patent Term Extension
- Patent Trials
- Personalized Medicine
- Prometheus
- Reasonable Royalty
- Reexam
- Supreme Court Decisions
- Uncategorized
- USPTO Board Decisions
- USPTO Proposed Rule Changes
- Written Description
Recent Updates
Twitter Updates
@PharmaPatents PharmaPatents' Recent Twitter Posts
- RT @LXBN: Supreme Court Finds For Monsanto In Seed Harvesting Case http://t.co/otl9Pbs0Q2 - @PharmaPatents
(about 2 days ago) - RT @priorsmart: Just read: Supreme Court Finds For Monsanto In Seed Harvesting Case - http://t.co/70U6m8vVvw [at @pharmapatents] #patent
(about 3 days ago) - New article: Supreme Court Finds For Monsanto In Seed Harvesting Case http://t.co/EAntMxrPzV ##patent
(about 3 days ago) - RT @BHoopes_Patents: Still can't believe the #CAFC #CLSBank opinion. A wonderful summary of the madness from @PharmaPatents: http://t.co/40…
(about 5 days ago) - @BHoopes_Patents Thanks!
(about 5 days ago)
